Complement-related molecular events in sepsis leading to heart failure

Molecular Immunology

Volumn 44, Issue 1-3, 2007, Pages 95-102

  Hoesel, Laszlo M ^a   Niederbichler, Andreas D ^b   Ward, Peter A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cardiomyocytes; Complement system; Multi organ failure; Sepsis; Septic cardiomyopathy

Indexed keywords

ANAPHYLATOXIN; CELL ADHESION MOLECULE; CHEMOKINE; COMPLEMENT; COMPLEMENT COMPONENT C5 INHIBITOR; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; CYTOKINE; CYTOKINE RECEPTOR ANTAGONIST; HIGH MOBILITY GROUP B1 PROTEIN; LIPOPOLYSACCHARIDE; MACROPHAGE MIGRATION INHIBITION FACTOR; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL INFECTION; BASOPHIL; BONE MARROW CELL; BURN; CARDIOMYOPATHY; CATECHOLAMINE BLOOD LEVEL; CELL ADHESION; COMPLEMENT SYSTEM; CYTOKINE PRODUCTION; ENDOTOXEMIA; EOSINOPHIL; ESCHERICHIA COLI; FLUID RESUSCITATION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; INNATE IMMUNITY; KIDNEY TUBULE CELL; LIVER CELL; LUNG ALVEOLUS CELL; MEAN ARTERIAL PRESSURE; MONOCYTE; MORTALITY; MULTIPLE ORGAN FAILURE; MYCOSIS; NEUTROPHIL; NONHUMAN; PARASITOSIS; PARENCHYMA; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VIRUS INFECTION;

ANIMALS; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; HEART; HEART FAILURE, CONGESTIVE; HMGB1 PROTEIN; HUMANS; INFLAMMATION; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MEMBRANE PROTEINS; NITRIC OXIDE; RECEPTORS, COMPLEMENT; SEPSIS;

ANIMALIA;

EID: 33750435578     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.06.009     Document Type: Article

References (82)

1. Bengtson A., and Heideman M. Anaphylatoxin formation in sepsis. Arch. Surg. 123 (1988) 645-649
2. Cain S.A., and Monk P.N. The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74). J. Biol. Chem. 277 (2002) 7165-7169
3. Chagnon F., Bentourkia M., Lecomte R., Lessard M., and Lesur O. Endotoxin-induced heart dysfunction in rats: assessment of myocardial perfusion and permeability and the role of fluid resuscitation. Crit. Care Med. 34 (2006) 127-133
4. Chagnon F., Metz C.N., Bucala R., and Lesur O. Endotoxin-induced myocardial dysfunction: effects of macrophage migration inhibitory factor neutralization. Circ. Res. 96 (2005) 1095-1102
5. Chen H.W., Hsu C., Lu T.S., Wang S.J., and Yang R.C. Heat shock pretreatment prevents cardiac mitochondrial dysfunction during sepsis. Shock 20 (2003) 274-279
6. Chenoweth D.E., and Hugli T.E. Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. U.S.A. 75 (1978) 3943-3947
7. Comstock K.L., Krown K.A., Page M.T., Martin D., Ho P., Pedraza M., Castro E.N., Nakajima N., Glembotski C.C., Quintana P.J., and Sabbadini R.A. LPS-induced TNF-alpha release from and apoptosis in rat cardiomyocytes: obligatory role for CD14 in mediating the LPS response. J. Mol. Cell. Cardiol. 30 (1998) 2761-2775
8. Cowan D.B., Poutias D.N., Del Nido P.J., and McGowan Jr. F.X. CD14-independent activation of cardiomyocyte signal transduction by bacterial endotoxin. Am. J. Physiol. Heart Circ. Physiol. 279 (2000) H619-H629
9. Czermak B.J., Sarma V., Pierson C.L., Warner R.L., Huber-Lang M., Bless N.M., Schmal H., Friedl H.P., and Ward P.A. Protective effects of C5a blockade in sepsis. Nat. Med. 5 (1999) 788-792
10. de Boer J.P., Creasey A.A., Chang A., Roem D., Eerenberg A.J., Hack C.E., and Taylor Jr. F.B. Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation pattern. Infect. Immun. 61 (1993) 4293-4301
11. Dong L.W., Wu L.L., Ji Y., and Liu M.S. Impairment of the ryanodine-sensitive calcium release channels in the cardiac sarcoplasmic reticulum and its underlying mechanism during the hypodynamic phase of sepsis. Shock 16 (2001) 33-39
12. Dumitru C.D., Ceci J.D., Tsatsanis C., Kontoyiannis D., Stamatakis K., Lin J.H., Patriotis C., Jenkins N.A., Copeland N.G., Kollias G., and Tsichlis P.N. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103 (2000) 1071-1083
13. Ferreira F.L., Bota D.P., Bross A., Melot C., and Vincent J.L. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 286 (2001) 1754-1758
14. Fiuza C., Bustin M., Talwar S., Tropea M., Gerstenberger E., Shelhamer J.H., and Suffredini A.F. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 101 (2003) 2652-2660
15. Frantz S., Kobzik L., Kim Y.D., Fukazawa R., Medzhitov R., Lee R.T., and Kelly R.A. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J. Clin. Invest. 104 (1999) 271-280
16. Gao H., Guo R.F., Speyer C.L., Reuben J., Neff T.A., Hoesel L.M., Riedemann N.C., McClintock S.D., Sarma J.V., Van Rooijen N., Zetoune F.S., and Ward P.A. Stat3 activation in acute lung injury. J. Immunol. 172 (2004) 7703-7712
17. Garner L.B., Willis M.S., Carlson D.L., DiMaio J.M., White M.D., White D.J., Adams G.A.t., Horton J.W., and Giroir B.P. Macrophage migration inhibitory factor is a cardiac-derived myocardial depressant factor. Am. J. Physiol. Heart Circ. Physiol. 285 (2003) H2500-H2509
18. Gerard N.P., and Gerard C. The chemotactic receptor for human C5a anaphylatoxin. Nature 349 (1991) 614-617
19. Gerard N.P., Hodges M.K., Drazen J.M., Weller P.F., and Gerard C. Characterization of a receptor for C5a anaphylatoxin on human eosinophils. J. Biol. Chem. 264 (1989) 1760-1766
20. Goyert S.M., and Haziot A. Recombinant soluble CD14 inhibits LPS-induced mortality in a murine model. Prog. Clin. Biol. Res. 392 (1995) 479-483
21. Guo R.F., Riedemann N.C., Bernacki K.D., Sarma V.J., Laudes I.J., Reuben J.S., Younkin E.M., Neff T.A., Paulauskis J.D., Zetoune F.S., and Ward P.A. Neutrophil C5a receptor and the outcome in a rat model of sepsis. FASEB J. 17 (2003) 1889-1891
22. Guo R.F., and Ward P.A. Mediators and regulation of neutrophil accumulation in inflammatory responses in lung: insights from the IgG immune complex model. Free Radic. Biol. Med. 33 (2002) 303-310
23. Hasunuma R., Maruyama H., Takimoto H., Ryll R., Tanaka S., and Kumazawa Y. Does high mobility group 1 protein function as a late mediator for LPS- or TNF-induced shock in galactosamine-sensitized mice?. J. Endotoxin Res. 8 (2002) 391-398
24. Haudek S.B., Spencer E., Bryant D.D., White D.J., Maass D., Horton J.W., Chen Z.J., and Giroir B.P. Overexpression of cardiac I-kappaBalpha prevents endotoxin-induced myocardial dysfunction. Am. J. Physiol. Heart Circ. Physiol. 280 (2001) H962-H968
25. Haviland D.L., McCoy R.L., Whitehead W.T., Akama H., Molmenti E.P., Brown A., Haviland J.C., Parks W.C., Perlmutter D.H., and Wetsel R.A. Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung. J. Immunol. 154 (1995) 1861-1869
26. Haziot A., Ferrero E., Lin X.Y., Stewart C.L., and Goyert S.M. CD14-deficient mice are exquisitely insensitive to the effects of LPS. Prog. Clin. Biol. Res. 392 (1995) 349-351
27. Haziot A., Rong G.W., Bazil V., Silver J., and Goyert S.M. Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-alpha production by cells in whole blood. J. Immunol. 152 (1994) 5868-5876
28. Hebert P.C., Drummond A.J., Singer J., Bernard G.R., and Russell J.A. A simple multiple system organ failure scoring system predicts mortality of patients who have sepsis syndrome. Chest 104 (1993) 230-235
29. Hoesel L.M., Neff T.A., Neff S.B., Younger J.G., Olle E.W., Gao H., Pianko M.J., Bernacki K.D., Sarma J.V., and Ward P.A. Harmful and protective roles of neutrophils in sepsis. Shock 24 (2005) 40-47
30. Hoesel L.M., and Ward P.A. Mechanisms of inflammatory response syndrome in sepsis. Drug Discov. Today: Dis. Mech. 1 (2004) 345-350
31. Horton J.W. Left ventricular contractile dysfunction as a complication of thermal injury. Shock 22 (2004) 495-507
32. Horton J.W., Maass D.L., White D.J., Sanders B., and Murphy J. Effects of burn serum on myocardial inflammation and function. Shock 22 (2004) 438-445
33. Huber-Lang M., Sarma V.J., Lu K.T., McGuire S.R., Padgaonkar V.A., Guo R.F., Younkin E.M., Kunkel R.G., Ding J., Erickson R., Curnutte J.T., and Ward P.A. Role of C5a in multiorgan failure during sepsis. J. Immunol. 166 (2001) 1193-1199
34. Huber-Lang M.S., Younkin E.M., Sarma J.V., McGuire S.R., Lu K.T., Guo R.F., Padgaonkar V.A., Curnutte J.T., Erickson R., and Ward P.A. Complement-induced impairment of innate immunity during sepsis. J. Immunol. 169 (2002) 3223-3231
35. Hwang T.L., and Yeh C.C. Hemodynamic and hepatic microcirculational changes in endotoxemic rats treated with different NOS inhibitors. Hepatogastroenterology 50 (2003) 188-191
36. Khadour F.H., Panas D., Ferdinandy P., Schulze C., Csont T., Lalu M.M., Wildhirt S.M., and Schulz R. Enhanced NO and superoxide generation in dysfunctional hearts from endotoxemic rats. Am. J. Physiol. Heart Circ. Physiol. 283 (2002) H1108-H1115
37. Kirov M.Y., Evgenov O.V., Evgenov N.V., Egorina E.M., Sovershaev M.A., Sveinbjornsson B., Nedashkovsky E.V., and Bjertnaes L.J. Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study. Crit. Care Med. 29 (2001) 1860-1867
38. Krishnagopalan S., Kumar A., and Parrillo J.E. Myocardial dysfunction in the patient with sepsis. Curr. Opin. Crit. Care 8 (2002) 376-388
39. Kumar A., Brar R., Wang P., Dee L., Skorupa G., Khadour F., Schulz R., and Parrillo J.E. Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. Am. J. Physiol. 276 (1999) R265-R276
40. Kumar A., Haery C., and Parrillo J.E. Myocardial dysfunction in septic shock. Crit. Care Clin. 16 (2000) 251-287
41. Kumar A., Haery C., and Parrillo J.E. Myocardial dysfunction in septic shock. Part I. Clinical manifestation of cardiovascular dysfunction. J. Cardiothorac. Vasc. Anesth. 15 (2001) 364-376
42. Kurimoto Y., de Weck A.L., and Dahinden C.A. Interleukin 3-dependent mediator release in basophils triggered by C5a. J. Exp. Med. 170 (1989) 467-479
43. Leturcq D.J., Moriarty A.M., Talbott G., Winn R.K., Martin T.R., and Ulevitch R.J. Therapeutic strategies to block LPS interactions with its receptor. Prog. Clin. Biol. Res. 392 (1995) 473-477
44. Levy R.J., and Deutschman C.S. Evaluating myocardial depression in sepsis. Shock 22 (2004) 1-10
45. Levy R.J., Piel D.A., Acton P.D., Zhou R., Ferrari V.A., Karp J.S., and Deutschman C.S. Evidence of myocardial hibernation in the septic heart. Crit. Care Med. 33 (2005) 2752-2756
46. Lin W.J., and Yeh W.C. Implication of Toll-like receptor and tumor necrosis factor alpha signaling in septic shock. Shock 24 (2005) 206-209
47. Lompre A.M., Anger M., and Levitsky D. Sarco(endo)plasmic reticulum calcium pumps in the cardiovascular system: function and gene expression. J. Mol. Cell Cardiol. 26 (1994) 1109-1121
48. Maass D.L., Hybki D.P., White J., and Horton J.W. The time course of cardiac NF-kappaB activation and TNF-alpha secretion by cardiac myocytes after burn injury: contribution to burn-related cardiac contractile dysfunction. Shock 17 (2002) 293-299
49. Maass D.L., White J., and Horton J.W. IL-1beta and IL-6 act synergistically with TNF-alpha to alter cardiac contractile function after burn trauma. Shock 18 (2002) 360-366
50. Marshall J.C., Cook D.J., Christou N.V., Bernard G.R., Sprung C.L., and Sibbald W.J. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit. Care Med. 23 (1995) 1638-1652
51. Martin G.S., Mannino D.M., Eaton S., and Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348 (2003) 1546-1554
52. Misquitta C.M., Mack D.P., and Grover A.K. Sarco/endoplasmic reticulum Ca2+ (SERCA)-pumps: link to heart beats and calcium waves. Cell Calcium 25 (1999) 277-290
53. Muckart D.J., and Bhagwanjee S. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients. Crit. Care Med. 25 (1997) 1789-1795
54. Mungrue I.N., Gros R., You X., Pirani A., Azad A., Csont T., Schulz R., Butany J., Stewart D.J., and Husain M. Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. J. Clin. Invest. 109 (2002) 735-743
55. Nakae H., Endo S., Inada K., Takakuwa T., Kasai T., and Yoshida M. Serum complement levels and severity of sepsis. Res. Commun. Chem. Pathol. Pharmacol. 84 (1994) 189-195
56. Natanson C., Eichenholz P.W., Danner R.L., Eichacker P.Q., Hoffman W.D., Kuo G.C., Banks S.M., MacVittie T.J., and Parrillo J.E. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J. Exp. Med. 169 (1989) 823-832
57. Niederbichler A.D., Hoesel L.M., Westfall M.V., Gao H., Ipaktchi K.R., Sun L., Zetoune F.S., Su G.L., Arbabi S., Sarma J.V., Wang S.C., Hemmila M.R., and Ward P.A. An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction. J. Exp. Med. 203 (2006) 53-61
58. Niederbichler A.D., Westfall M.V., Su G.L., Donnerberg J., Usman A., Vogt P.M., Ipaktchi K.R., Arbabi S., Wang S.C., and Hemmila M.R. Cardiomyocyte function after burn injury and lipopolysaccharide exposure: single-cell contraction analysis and cytokine secretion profile. Shock 25 (2006) 176-183
59. Raeburn C.D., Calkins C.M., Zimmerman M.A., Song Y., Ao L., Banerjee A., Harken A.H., and Meng X. ICAM-1 and VCAM-1 mediate endotoxemic myocardial dysfunction independent of neutrophil accumulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283 (2002) R477-R486
60. Raeburn C.D., Calkins C.M., Zimmerman M.A., Song Y., Ao L., Banerjee A., Meng X., and Harken A.H. Vascular cell adhesion molecule-1 expression is obligatory for endotoxin-induced myocardial neutrophil accumulation and contractile dysfunction. Surgery 130 (2001) 319-325
61. Remick D.G. Cytokine therapeutics for the treatment of sepsis: why has nothing worked?. Curr. Pharm. Des. 9 (2003) 75-82
62. Riedemann N.C., Guo R.F., Bernacki K.D., Reuben J.S., Laudes I.J., Neff T.A., Gao H., Speyer C., Sarma V.J., Zetoune F.S., and Ward P.A. Regulation by C5a of neutrophil activation during sepsis. Immunity 19 (2003) 193-202
63. Riedemann N.C., Guo R.F., Sarma V.J., Laudes I.J., Huber-Lang M., Warner R.L., Albrecht E.A., Speyer C.L., and Ward P.A. Expression and function of the C5a receptor in rat alveolar epithelial cells. J. Immunol. 168 (2002) 1919-1925
64. Roshon M.J., Kline J.A., Thornton L.R., and Watts J.A. Cardiac UCP2 expression and myocardial oxidative metabolism during acute septic shock in the rat. Shock 19 (2003) 570-576
65. Smedegard G., Cui L.X., and Hugli T.E. Endotoxin-induced shock in the rat. A role for C5a. Am. J. Pathol. 135 (1989) 489-497
66. Szabo G., Romics Jr. L., and Frendl G. Liver in sepsis and systemic inflammatory response syndrome. Clin. Liver Dis. 6 (2002) 1045-1066
67. Takahashi M., Nishihira J., Shimpo M., Mizue Y., Ueno S., Mano H., Kobayashi E., Ikeda U., and Shimada K. Macrophage migration inhibitory factor as a redox-sensitive cytokine in cardiac myocytes. Cardiovasc. Res. 52 (2001) 438-445
68. Tao W., Deyo D.J., Traber D.L., Johnston W.E., and Sherwood E.R. Hemodynamic and cardiac contractile function during sepsis caused by cecal ligation and puncture in mice. Shock 21 (2004) 31-37
69. Thomas J.A., Tsen M.F., White D.J., and Horton J.W. IRAK contributes to burn-triggered myocardial contractile dysfunction. Am. J. Physiol. Heart Circ. Physiol. 283 (2002) H829-H836
70. Tracey K.J., Fong Y., Hesse D.G., Manogue K.R., Lee A.T., Kuo G.C., Lowry S.F., and Cerami A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330 (1987) 662-664
71. Treutiger C.J., Mullins G.E., Johansson A.S., Rouhiainen A., Rauvala H.M., Erlandsson-Harris H., Andersson U., Yang H., Tracey K.J., Andersson J., and Palmblad J.E. High mobility group 1 B-box mediates activation of human endothelium. J. Intern. Med. 254 (2003) 375-385
72. Ulevitch R.J., and Tobias P.S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13 (1995) 437-457
73. Ullrich R., Scherrer-Crosbie M., Bloch K.D., Ichinose F., Nakajima H., Picard M.H., Zapol W.M., and Quezado Z.M. Congenital deficiency of nitric oxide synthase 2 protects against endotoxin-induced myocardial dysfunction in mice. Circulation 102 (2000) 1440-1446
74. Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., Frazier A., Yang H., Ivanova S., Borovikova L., Manogue K.R., Faist E., Abraham E., Andersson J., Andersson U., Molina P.E., Abumrad N.N., Sama A., and Tracey K.J. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285 (1999) 248-251
75. Wang H., Yang H., Czura C.J., Sama A.E., and Tracey K.J. HMGB1 as a late mediator of lethal systemic inflammation. Am. J. Respir. Crit. Care Med. 164 (2001) 1768-1773
76. Ward P.A. The dark side of C5a in sepsis. Nat. Rev. Immunol. 4 (2004) 133-142
77. Watts J.A., Kline J.A., Thornton L.R., Grattan R.M., and Brar S.S. Metabolic dysfunction and depletion of mitochondria in hearts of septic rats. J. Mol. Cell Cardiol. 36 (2004) 141-150
78. Werfel T., Oppermann M., Schulze M., Krieger G., Weber M., and Gotze O. Binding of fluorescein-labeled anaphylatoxin C5a to human peripheral blood, spleen, and bone marrow leukocytes. Blood 79 (1992) 152-160
79. Wrzosek A. Regulation of Ca2+ release from internal stores in cardiac and skeletal muscles. Acta Biochim. Pol. 47 (2000) 705-723
80. Wu L.L., Ji Y., Dong L.W., and Liu M.S. Calcium uptake by sarcoplasmic reticulum is impaired during the hypodynamic phase of sepsis in the rat heart. Shock 15 (2001) 49-55
81. Wu L.L., and Liu M.S. Impaired calcium uptake by cardiac sarcoplasmic reticulum and its underlying mechanism in endotoxin shock. Mol. Cell Biochem. 108 (1991) 9-17
82. Yang H., Wang H., Czura C.J., and Tracey K.J. HMGB1 as a cytokine and therapeutic target. J. Endotoxin Res. 8 (2002) 469-472